BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 29771595)

  • 1. Mainstreaming implementation science into immunization systems in the decade of vaccines: A programmatic imperative for the African Region.
    Adamu AA; Adamu AL; Dahiru AI; Uthman OA; Wiysonge CS
    Hum Vaccin Immunother; 2018; 14(10):2443-2446. PubMed ID: 29771595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancing access to immunization services and exploiting the benefits of recent innovations in the African region.
    Okeibunor JC; Akanmori BD; Balcha GM; Mihigo R; Vaz RM; Nshimirimana D
    Vaccine; 2013 Aug; 31(37):3772-6. PubMed ID: 23800541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advocating for efforts to protect African children, families, and communities from the threat of infectious diseases: report of the First International African Vaccinology Conference.
    Wiysonge CS; Waggie Z; Hawkridge A; Schoub B; Madhi SA; Rees H; Hussey G
    Pan Afr Med J; 2016; 23():53. PubMed ID: 27217879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 and routine childhood immunization in Africa: Leveraging systems thinking and implementation science to improve immunization system performance.
    Adamu AA; Jalo RI; Habonimana D; Wiysonge CS
    Int J Infect Dis; 2020 Sep; 98():161-165. PubMed ID: 32592908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positioning implementation science in national immunization programmes to improve coverage equity and advance progress toward Immunization Agenda 2030: An urgent global health imperative.
    Adamu AA; Ndwandwe D; Jalo RI; Wiysonge CS
    Hum Vaccin Immunother; 2024 Dec; 20(1):2331872. PubMed ID: 38556477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New vaccine introduction in the East and Southern African sub-region of the WHO African region in the context of GIVS and MDGs.
    Chauke-Moagi BE; Mumba M
    Vaccine; 2012 Sep; 30 Suppl 3():C3-8. PubMed ID: 22939018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strengthening vaccination policies in Latin America: an evidence-based approach.
    Tapia-Conyer R; Betancourt-Cravioto M; Saucedo-Martínez R; Motta-Murguía L; Gallardo-Rincón H
    Vaccine; 2013 Aug; 31(37):3826-33. PubMed ID: 23357196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SMS-reminder for vaccination in Africa: research from published, unpublished and grey literature.
    Manakongtreecheep K
    Pan Afr Med J; 2017; 27(Suppl 3):23. PubMed ID: 29296158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Costs of vaccine programs across 94 low- and middle-income countries.
    Portnoy A; Ozawa S; Grewal S; Norman BA; Rajgopal J; Gorham KM; Haidari LA; Brown ST; Lee BY
    Vaccine; 2015 May; 33 Suppl 1():A99-108. PubMed ID: 25919184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunization programme in urban areas in Cameroon: a case study of the Djoungolo Health District].
    Ngomba AV; Kollo B; Bita AF; Djouma FN; Edengue JM; Elongue MJ; Adiogo D
    Pan Afr Med J; 2016; 25():213. PubMed ID: 28292168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of email-based reminders to increase vaccine uptake: a systematic review.
    Frascella B; Oradini-Alacreu A; Balzarini F; Signorelli C; Lopalco PL; Odone A
    Vaccine; 2020 Jan; 38(3):433-443. PubMed ID: 31806532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What have we learned on costs and financing of routine immunization from the comprehensive multi-year plans in GAVI eligible countries?
    Brenzel L
    Vaccine; 2015 May; 33 Suppl 1():A93-8. PubMed ID: 25919183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Challenges for nationwide vaccine delivery in African countries.
    Songane M
    Int J Health Econ Manag; 2018 Jun; 18(2):197-219. PubMed ID: 29047019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Innovations in vaccinology: challenge and opportunities for Africa].
    Diop D; Sanicas M
    Pan Afr Med J; 2017; 26():235. PubMed ID: 28690749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strategies for decision-making on vaccine use: the French experience.
    Loulergue P; Floret D; Launay O
    Expert Rev Vaccines; 2015 Jul; 14(7):917-22. PubMed ID: 25913015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cost structure of routine infant immunization services: a systematic analysis of six countries.
    Geng F; Suharlim C; Brenzel L; Resch SC; Menzies NA
    Health Policy Plan; 2017 Oct; 32(8):1174-1184. PubMed ID: 28575193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunization and Vaccine-related Implementation Research Advisory Committee (IVIR-AC): summary of conclusions and recommendations, 9-11 June 2015 meeting. THEME: Research to minimize barriers and improve coverage of vaccines currently in use.
    Wkly Epidemiol Rec; 2015 Sep; 90(37):477-84. PubMed ID: 26364328
    [No Abstract]   [Full Text] [Related]  

  • 18. Developing vaccinology expertise for Africa: fifteen years and counting.
    Amponsah-Dacosta E; Muloiwa R; Wiysonge CS; Gold M; Hussey G; Kagina BM
    Pan Afr Med J; 2021; 38():313. PubMed ID: 34285736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Cape Town Declaration on Vaccines 2012: Unlocking the full potential of vaccines in Africa.
    Wiysonge CS; Waggie Z; Hawkridge A; Schoub BD; Madhi SA; Rees H; Hussey GD;
    Vaccine; 2016 Jul; 34(33):3713-4. PubMed ID: 27317265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reaching every district (RED) approach to strengthen routine immunization services: evaluation in the African region, 2005.
    Ryman T; Macauley R; Nshimirimana D; Taylor P; Shimp L; Wilkins K
    J Public Health (Oxf); 2010 Mar; 32(1):18-25. PubMed ID: 19542268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.